Valdecoxib

NOTE: April 7, 2005, Pfizer agreed to suspend sales and marketing of Bextra in the U.S., pending further discussions with the with the FDA. For more information, please read the FDA press release.

Valdecoxib: Generic name of a cox-2 inhibitor. See: Bextra.